α-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: Role in IFN-γ

European Journal of Immunology

Volumn 35, Issue 10, 2005, Pages 2793-2802

  Hachem, Patricia ^a   Lisbonne, Mariette ^a   Michel, Marie Laure ^a   Diem, Séverine ^a   Roongapinun, Sukit ^b   Lefort, Jean ^c   Marchal, Gilles ^c   Herbelin, André ^a   Askenase, Philip W ^b   Dy, Michel ^a   Leite de Moraes, Maria C ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT PASTEUR   (France)

Author keywords

GalCer; Ashtma; Hyper reactivity; Immunotherapy; NKT cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN;

ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DRUG TARGETING; EOSINOPHILIA; HISTOPATHOLOGY; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; SENSITIZATION;

ADMINISTRATION, INTRANASAL; ADOPTIVE TRANSFER; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HYPERSENSITIVITY; INJECTIONS, INTRAVENOUS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; MICE; OVALBUMIN;

EID: 27644586260     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535268     Document Type: Article

References (36)

1. Wills-Karp, M., Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 1999. 17: 255-281.
2. Foster, P. S., Mould, A. W., Yang, M., Mackenzie, J., Mattes, J., Hogan, S. P., Mahalingam, S. et al., Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 2001. 179: 173-181.
3. Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C. and DeKruyff, R. H., Asthma: An epidemic of dysregulated immunity. Nat. Immunol. 2002. 3: 715-720.
4. Herrick, C. A. and Bottomly, K., To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 2003. 3: 405-412.
5. Cohn, L., Elias, J. A. and Chupp, G. L., Asthma: Mechanisms of disease persistence and progression. Annu. Rev. Immunol. 2004. 22: 789-815.
6. Lisbonne, M., Diem, S., Castro-Keller, A., Lefort, J., Araujo, L. M., Hachem, P., Fourneau, J.-M. et al., Cutting Edge: Invariant Vα14 NKT cells are required for allergen-induced airwway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 2003. 171: 1637-1641.
7. Akbari, O., Stock, P., Meyer, E., Kronenberg, M., Sidobre, S., Nakayama, T., Taniguchi, M. et al., Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003. 189: 553-588.
8. Araujo, L. M., Lefort, J., Nahori, M. A., Diem, S., Zhu, R., Dy, M., Leite-deMoraes, M. C. et al., Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoinurnme diabetes-prone NOD mice: A critical role for CD1d-dependent NKT cells. Eur. J. Immunol. 2004. 34: 327-335.
9. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
10. Lisbonne, M. and Leite-de-Moraes, M. C., Invariant Vα14 NKT lymphocytes: A double-edged immuno-regulatory T cell population. Eur. Cytokine Netw. 2003. 14: 4-14.
11. Godfrey, D. I. and Kronenberg, M., Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004. 114: 1379-1388.
12. Kronenberg, M., Toward an understanding of NKT cell biology: Progress and paradoxes. Annu. Rev. Immunol. 2005. 23: 877-900.
13. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H. et al., CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997. 278: 1626-1629.
14. Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S. and Kaer, L. V., CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997. 6: 469.
15. Zhou, D., Mattner, J., Cantu, C. R., Schrantz, N., Yin, N., Gao, Y., Sagiv, Y. et al., Lysosomal glycosphingolipid recognition by NKT cells. Science 2004, 306: 1786-1789.
16. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M. et al., Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 2001. 7: 1057-1062.
17. Miyamoto, K., Miyake, S. and Yamamura, T., A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2 bias of natural killer T cells. Nature 2001. 413: 531-534.
18. Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H. and Godfrey, D. I., Sequential production of interferon-gamma by NK1.1 (+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002. 99: 1259-1266.
19. Gonzalez-Aseguinolaza, G., Van Kaer, L., Bergmann, C. C., Wilson, J. M., Schmieg, J., Kromenberg, M., Nakayama, T. et al., Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 2002. 195: 617-624.
20. Fujii, S., Shimizu, K., Kronenberg, M. and Steinman, R. M., Prolonged IFN-gamma-producing NKT response induced with alpha- galactosykeramide-loaded DCs. Nat. Immunol. 2002. 3: 867-874.
21. Nieuwenhuis, E. E., Matsumoto, T., Exley, M., Schleipman, R. A., Glickman, J., Bailey, D. T., Corazza, N. et al., CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 2002. 8: 588-593.
22. Kim, J. O., Kim, D. H., Chang, W. S., Hong, C., Park, S. H., Kim, S. and Kang, C. Y., Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model. J. Allergy Clin. Immunol. 2004. 114: 1332-1338.
23. Ishimitsu, R., Yajima, T., Nishimura, H., Kawauchi, H. and Yoshikai, Y., NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E. Eur. J. Immunol. 2003. 33: 183-193.
24. Chung, Y., Chang, W. S., Kim, S. and Kang, C. Y., NKT cell ligand alpha-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Eur. J. Immunol. 2004. 34: 2471-2479.
25. Matsuda, H., Suda, T., Sato, J., Nagata, T., Koide, Y., Chida, K. and Nakamura, H., {alpha}-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir. Cell. Mol. Biol. 2005. 31: 22-31.
26. Mattner, J., Debord, K. L., Ismail, N., Goff, R. D., Cantu, C. R., Zhou, D., Saint-Mezard, P. et al., Exogenous and endogerious glycolipid antigens activate NKT cells during microbial infections. Nature 2005. 434: 525-529.
27. Leite-de-Moraes, M. C., Lisbonne, M., Arnould, A., Machavoine, F., Herbelin, A., Dy, M. and Schneider, E., Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment. Eur. J. Immunol. 2002. 32: 1897-1904.
28. Lack, G., Bradley, K. L., Hamelmann, E., Renz, H., Loader, J., Leung, D. Y., Larsen, G. and Gelfand, E. W., Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J. Immunol. 1996. 157: 1432-1439.
29. Walter, D. M., Wong, C. P., DeKruyff, R. H., Berry, G. J., Levy, S. and Umetsu, D. T., IL-18 gene transfer by adenovirus prevents the development of and reverses established allergen-induced airway hyperreactivity. J. Immunol. 2001. 166: 6392-6398.
30. Stock, P., Akbari, O., Berry, G., Freeman, G. J., DeKruyff, R. H. and Umetsu, D. T., Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat. Immunol. 2004. 5: 1149-1156.
31. Kuipers, H. and Lambrecht, B. N., The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr. Opin. Immunol. 2004. 16: 702-708.
32. Hawrylowicz, C. M. and O'Garra, A., Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat. Rev. Immunol. 2005. 5: 271-283.
33. Cui, J., Shin, T., Kawano, T., Sato, H., Kondo, E., Toura, I., Kaneko, Y. et al., Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997. 278: 1623-1626.
34. + effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J. Exp. Med. 1994. 179: 1367-1371.
35. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
36. Lisbonne, M., Hachem, P., Tonanny, M. B., Fourneau, J.-M., Sidobre, S., Kronenberg, M., Endert, P. V. et al., In vivo activation of invariant Vα14 natural killer T cells by α-GalCer sequentially induces fas-dependent and independent cytotoxicity. Eur. J. Immunol. 2004. 34: 1381-1388.